Molecular biological study\ies in a novel peripheral nerve myelin protein and its application to clinical neurology
新型周围神经髓鞘蛋白的分子生物学研究及其在临床神经病学中的应用
基本信息
- 批准号:09670643
- 负责人:
- 金额:$ 1.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We tried to characterize a 35-kd antigen recognized by the serum IgG of a patient with malignant lymphoma and peripheral neuropathy. On western blotting, the serum IgG reacted with a 35-kd antigen in human, bovine and mouse peripheral nerves (PN) but not with other neural and non-neural tissues. Immunohistochemical analysis showed immunoreactivity for the IgG in the compact myelin of PN. We constructed a human sciatic nerve cDNA library and screened it using the patient's IgG. We identified three independent clones. A homology search of the inserts of these clones revealed that the inserts were homologous to P0 cDNA. However, all the inserts corresponded to the 3'-untranslational region of P0 cDNA. Then, to analyze the 35-kd antigen biochmically, myelin fractions of human and bovine sciatic nerve were prepared. Using SDS-polyacrylamide gel electrophresis, the 35-kd antigen was purified from the crude myelin fraction. When the immunoreactivities of the 35-kd antigen for the patient's IgG and monoclonal anti-P0 antibody were compared with those of protein P0 for these antibodies, the 35-kd antigen reacted with both the antibodies, but P0 reacted with only monoclonal anti-P0 antibody. These results indicate the possibility of the 35-kd antigen being an isoform of P0. However, the presence of these autoantibodies against the 35-kd antigen seems to be of little pathological significance, because circulating autoantibodies against the antigen were also found in the sera of patients with malignant lymphoma without associated peripheral neuropathy.
我们试图表征恶性淋巴瘤和周围神经病患者血清 IgG 识别的 35-kd 抗原。在蛋白质印迹中,血清 IgG 与人、牛和小鼠周围神经 (PN) 中的 35 kd 抗原发生反应,但不与其他神经和非神经组织发生反应。免疫组织化学分析显示 PN 致密髓磷脂中的 IgG 具有免疫反应性。我们构建了人类坐骨神经 cDNA 文库,并使用患者的 IgG 对其进行了筛选。我们鉴定了三个独立的克隆。对这些克隆的插入片段进行同源性搜索表明,插入片段与 P0 cDNA 同源。然而,所有插入片段均对应于 P0 cDNA 的 3'-非翻译区。然后,为了对 35-kd 抗原进行生物化学分析,制备了人和牛坐骨神经的髓磷脂部分。使用 SDS 聚丙烯酰胺凝胶电泳,从粗髓磷脂部分中纯化出 35-kd 抗原。当将患者 IgG 和单克隆抗 P0 抗体的 35-kd 抗原的免疫反应性与这些抗体的蛋白 P0 的免疫反应性进行比较时,35-kd 抗原与两种抗体都发生反应,但 P0 仅与单克隆抗-P0 抗体发生反应。这些结果表明 35-kd 抗原可能是 P0 的同种型。然而,这些针对 35-kd 抗原的自身抗体的存在似乎没有什么病理意义,因为在没有相关周围神经病变的恶性淋巴瘤患者的血清中也发现了针对该抗原的循环自身抗体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FURUKAWA Tetsuo其他文献
FURUKAWA Tetsuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FURUKAWA Tetsuo', 18)}}的其他基金
Learning theory for higher-knowledge self-organization from experiences
从经验中学习更高知识自组织的理论
- 批准号:
23500280 - 财政年份:2011
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of generalized theory of self-organizing maps and its applications
自组织映射广义理论的建立及其应用
- 批准号:
17500193 - 财政年份:2005
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study in cDNA Cloning of Peripheral Myelin-Specific Antigen Associated with Autoimmune Peripheral Neuritis.
与自身免疫性周围神经炎相关的周围髓磷脂特异性抗原的cDNA克隆研究。
- 批准号:
06670645 - 财政年份:1994
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
A novel medical device for reducing chemotherapy-induced peripheral neuropathy in the hands
一种减少化疗引起的手部周围神经病变的新型医疗设备
- 批准号:
MR/Z503800/1 - 财政年份:2024
- 资助金额:
$ 1.47万 - 项目类别:
Research Grant
The Role of Astrocyte Elevated Gene-1 (AEG-1), A Novel Multifunctional Protein, In Chemotherapy-Induced Peripheral Neuropathy
星形胶质细胞升高基因 1 (AEG-1)(一种新型多功能蛋白)在化疗引起的周围神经病变中的作用
- 批准号:
10679708 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Regulation of Schwann Cell Mitochondria Homeostasis in Painful Peripheral Neuropathy
疼痛性周围神经病中雪旺细胞线粒体稳态的调节
- 批准号:
10790951 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Development of an Integrated Risk Prediction Model of Taxane-induced Peripheral Neuropathy
紫杉烷诱发的周围神经病变综合风险预测模型的开发
- 批准号:
10566077 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Advancing Development of Novel Immunotherapy for Chemotherapy-induced Peripheral Neuropathy (CIPN)
推进化疗引起的周围神经病变 (CIPN) 的新型免疫疗法的发展
- 批准号:
10588384 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Establishment of preventive care that directly approaches the mechanism of chemotherapy-induced peripheral neuropathy
建立直接探讨化疗引起的周围神经病变机制的预防护理
- 批准号:
23K09882 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a hybrid therapy for prevention of foot ulcers in patients with diabetic peripheral neuropathy.
开发预防糖尿病周围神经病变患者足部溃疡的混合疗法。
- 批准号:
23K16627 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The efficacy of the combined treatment with gabapentinoids and goshajinkigan for chemotherapy induced peripheral neuropathy
加巴喷丁类药物与戈沙金吉甘联合治疗化疗所致周围神经病变的疗效
- 批准号:
23K15605 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Clinical biomarker for early prediction of chemotherapy-induced peripheral neuropathy
早期预测化疗引起的周围神经病变的临床生物标志物
- 批准号:
10604018 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy
CART II 在化疗引起的周围神经病变中的抗伤害作用
- 批准号:
10719026 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:














{{item.name}}会员




